Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-049970

EVP, Research & CSO sold 3,805 shares at an average $29.99 ($114,098)

  • EVP, Research & CSO acquired 3,805 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2020-09-08 Option exercise +3,805 $1.53 $5,822 23,805 D
Virgin Herbert EVP, Research & CSO 2020-09-08 Sale −1,465 $30.00 $43,950 22,340 D
Virgin Herbert EVP, Research & CSO 2020-09-08 Sale −2,340 $29.98 $70,148 20,000 D
Derivatives
Virgin Herbert EVP, Research & CSO 2020-09-08 Option exercise · Stock Option (Right to Buy) −3,805 470,890 D
Open-market sales · 3,805 sh · avg $29.99 · $114,098
Loading xslF345X03/doc4.xml…